Scientists to test diagnostic tool for Alzheimer's

06/18/2009 | MIT Technology Review

Scientists at the Blanchette Rockefeller Neurosciences Institute are planning to conduct a large-scale study needed to commercialize a skin test that can pinpoint patients with Alzheimer's disease. The diagnostic test works by identifying a class of enzymes, called PKCs, that becomes defective in patients with the condition.

View Full Article in:

MIT Technology Review

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Actuarial Services, Government Programs
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC
Counsel I – Clinical Contracts
Gilead Sciences
Foster City, CA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Vice President, Idaho Regional Director
Boise, ID